Key Data

Key Data

   [Table 1.1]
  2013 2014 Change
  € million € million %
Bayer Group      
Sales 40,157 42,239 +5.2
EBIT1 4,934 5,506 +11.6
EBIT before special items2 5,773 5,944 +3.0
EBITDA3 7,830 8,442 +7.8
EBITDA before special items2 8,401 8,812 +4.9
EBITDA margin before special items4 20.9% 20.9%  
Income before income taxes 4,207 4,525 +7.6
Net income 3,189 3,426 +7.4
Earnings per share (€)5 3.86 4.14 +7.3
Core earnings per share (€)6 5.61 6.02 +7.3
Gross cash flow7 5,832 6,820 +16.9
Net cash flow8 5,171 5,810 +12.4
Net financial debt 6,731 19,612 .
Capital expenditures as per segment table 2,155 2,490 +15.5
Research and development expenses 3,406 3,574 +4.9
Dividend per Bayer AG share (€) 2.10 2.25 +7.1
HealthCare      
Sales 18,924 19,975 +5.6
EBIT 3,260 3,581 +9.8
EBIT before special items2 3,973 3,912 -1.5
EBITDA3 4,858 5,186 +6.8
EBITDA before special items2 5,334 5,484 +2.8
EBITDA margin before special items4 28.2% 27.5%  
Gross cash flow7 3,573 4,011 +12.3
Net cash flow8 2,980 4,444 +49.1
CropScience      
Sales 8,819 9,494 +7.7
EBIT 1,729 1,806 +4.5
EBIT before special items2 1,801 1,838 +2.1
EBITDA3 2,184 2,358 +8.0
EBITDA before special items2 2,248 2,360 +5.0
EBITDA margin before special items4 25.5% 24.9%  
Gross cash flow7 1,590 1,835 +15.4
Net cash flow8 682 950 +39.3
MaterialScience      
Sales 11,238 11,651 +3.7
EBIT 435 555 +27.6
EBIT before special items2 429 598 +39.4
EBITDA3 1,101 1,149 +4.4
EBITDA before special items2 1,072 1,187 +10.7
EBITDA margin before special items4 9.5% 10.2%  
Gross cash flow7 887 961 +8.3
Net cash flow8 977 880 -9.9
Employees      
Number of employees9 (Dec. 31) 112,366 118,888 +5.8
Proportion of women in senior management (%) 25 26  
Number of nationalities in the Group Leadership Circle 31 35 +12.9
Proportion of employees with health insurance (%) 95 96  
Proportion of employees covered by collective agreements on pay and conditions (%) 54 52  
Safety10      
Recordable Incident Rate for Bayer employees (RIR) 0.47 0.43 -9.4
Lost Time Recordable Incident Rate for Bayer employees (LTRIR) 0.26 0.22 -13.2
Loss of Primary Containment Incident Rate (LoPC-IR)11 0.35 0.23 -33.1
Number of transport incidents 11 12 +9.1
Environmental Protection10      
Direct greenhouse gas emissions
(CO2 equivalents in million t)12
4.09 4.02 -1.7
Indirect greenhouse gas emissions
(CO2 equivalents in million t)12
4.29 4.70 +9.7
Volatile organic compounds (VOC)13
(thousand t/a)
2.27 2.12 -6.5
Ozone-depleting substances
(ODS) (t/a)14
15.65 14.79 -5.6
Total organic carbon (TOC)
(thousand t/a)
1.53 1.20 -21.6
Total phosphorus in wastewater
(thousand t/a)
0.11 0.10 -12.6
Total nitrogen in wastewater
(thousand t/a)
0.69 0.76 +11.3
Hazardous waste generated
(thousand t/a)
467 487 +4.4
Hazardous waste landfilled
(thousand t/a)
53 65 +21.4
Water use
(million m³/a)
361 350 -3.1
Primary energy consumption
(petajoules/a)15
47.58 45.57 -4.2
Secondary energy consumption
(petajoules/a)15
33.27 39.74 +19.5
Energy efficiency (MWh/t)16 3.44 3.37 -2.3

2013 figures restated
1 EBIT = earnings before financial result and taxes
2 EBIT before special items and EBITDA before special items are not defined in the International Financial Reporting Standards and should therefore be regarded only as supplementary information. EBITDA before special items is a more suitable indicator of operating performance since it is not affected by depreciation, amortization, impairment losses, impairment loss reversals or special items. By reporting this indicator, the company aims to give readers a clear picture of the results of operations and ensure comparability of data over time. See also Combined Management Report, Chapter 16.2 “Calculation of EBIT(DA) Before Special Items.”
3 EBITDA = EBIT plus amortization and impairment losses on intangible assets, plus depreciation and impairment losses on property, plant and equipment, minus impairment loss reversals. See also Combined Management Report, Chapter 16.2 “Calculation of EBIT(DA) Before Special Items.”
4 The EBITDA margin before special items is calculated by dividing EBITDA before special items by sales.
5 Earnings per share as defined in IAS 33 = net income divided by the average number of shares. For details see Note [16] to the consolidated financial statements.
6 Core earnings per share are not defined in the International Financial Reporting Standards. By reporting this indicator, the company aims to give readers a clear picture of the results of operations and ensure comparability of data over time. The calculation of core earnings per share is explained in the Combined Management Report, Chapter 16.3 “Core Earnings Per Share.”
7 Gross cash flow = income after income taxes, plus income taxes, plus financial result, minus income taxes paid or accrued, plus depreciation, amortization and impairment losses, minus impairment loss reversals, plus/minus changes in pension provisions, minus gains/plus losses on retirements of noncurrent assets, minus gains from the remeasurement of already held assets in step acquisitions. The change in pension provisions includes the elimination of non-cash components of EBIT. It also contains benefit payments during the year. For details see Combined Management Report, Chapter 16.5 “Liquidity and Capital Expenditures of the Bayer Group.”
8 Net cash flow = cash flow from operating activities according to IAS 7
9 Full-time equivalents
10 Percentage changes not based on rounded figures
11 LoPC-IR: rate of incidents in which chemicals leak from their primary container, such as pipelines, pumps, tanks or drums, per 200,000 working hours in areas relevant to plant safety
12 Portfolio-adjusted in accordance with the Greenhouse Gas Protocol
13 Volatile organic compounds (VOC) excluding methane
14 Ozone-depleting substances (ODS) in CFC-11 equivalents
15 1 petajoule = 1015 joules
16 Energy efficiency: quotient of total energy consumption and manufactured sales volume. For MaterialScience, only manufactured sales volumes that also form the basis for calculating MaterialScience-specific emissions are taken into account.

Last updated: February 26, 2015  Copyright © Bayer AG
http://www.annualreport2014.bayer.com